Ultram and Anaprox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ultram (tramadol hydrochloride) and Anaprox (naproxen sodium). Common drug interactions include anxiety among females and arteriosclerosis among males.

The phase IV clinical study analyzes what interactions people have when they take Ultram and Anaprox. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

What is Anaprox?

Anaprox has active ingredients of naproxen sodium. eHealthMe is studying from 1,370 Anaprox users. Check the latest studies of Anaprox.



On Jul, 07, 2026

35 people who take Ultram and Anaprox together, and have interactions are studied.

Ultram and Anaprox drug interactions.

What are the common drug interactions of Ultram and Anaprox, by gender? *:

female:

  1. Anxiety
  2. Arthropathy
  3. Atrioventricular block complete (heart block complete)
  4. Atrioventricular block first degree (heart block first degree)
  5. Blood iron increased
  6. Cachexia (loss of weight)
  7. Cardiac murmur (an heart sound in valve abnormality)
  8. Carotid bruit (sound heard over the carotid artery area during auscultation)
  9. Cervical cyst (mucus-filled cyst on the surface of the cervix)
  10. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)

male:

  1. Arteriosclerosis (thickening and hardening of arteries)
  2. Abdominal distension
  3. Irritable bowel syndrome
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Nephrolithiasis (calculi in the kidneys)
  6. Oedema peripheral (superficial swelling)
  7. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  8. Pulmonary oedema (fluid accumulation in the lungs)
  9. Vertigo
  10. Anaemia (lack of blood)

What are the common drug interactions of Ultram and Anaprox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anaemia (lack of blood)
  2. Brain death
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Liver disorder (liver diseases)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Migraine (headache)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Respiratory depression (respiration has a rate below 12 breaths)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

30-39:

  1. Alcoholism (problems with alcohol)
  2. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  3. Death
  4. Dependence
  5. Drug effect decreased
  6. Drug toxicity
  7. Fatigue (feeling of tiredness)
  8. Insomnia (sleeplessness)
  9. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  10. Migraine (headache)

40-49:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Aspartate aminotransferase increased
  3. Asthenia (weakness)
  4. Atrioventricular block second degree (heart block second degree)
  5. Blood alkaline phosphatase increased
  6. Blood bilirubin increased
  7. Bronchial secretion retention
  8. Cardiac disorder
  9. Cardiac failure congestive
  10. Cardioactive drug level above therapeutic

50-59:

  1. Renal failure (kidney dysfunction)
  2. Nausea (feeling of having an urge to vomit)
  3. Arthralgia (joint pain)
  4. Back pain
  5. Blood pressure increased
  6. Decreased appetite
  7. Flushing (the warm, red condition of human skin)
  8. Headache (pain in head)
  9. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  10. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)

60+:

  1. Anaemia (lack of blood)
  2. Drug hypersensitivity
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Intussusception
  5. Rectal haemorrhage (bleeding from anus)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 17.14%
  2. Migraine (headache): 4 people, 11.43%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 8.57%
  4. Gastric Disorder (disease of stomach): 3 people, 8.57%
  5. Depression: 3 people, 8.57%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 8.57%
  7. Stress And Anxiety: 2 people, 5.71%
  8. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 5.71%
  9. Hypersensitivity: 2 people, 5.71%
  10. High Blood Pressure: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Ultram and Anaprox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ultram and Anaprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Anaprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Anaprox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride and naproxen sodium (the active ingredients of Ultram and Anaprox, respectively), and Ultram and Anaprox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: